Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives
Environmental Toxicology and Pharmacology · 2023
DOI: 10.1016/j.etap.2023.104254 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Environmental Toxicology and Pharmacology, 2023. Verfasst von Kris Cooreman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Aquatic Environment and Quality, Animal Sciences Unit, Flanders Research Institute for Agriculture, Fisheries and Food, Jacobsenstraat 1, BE-8400 Ost…. Hauptthemen laut MEDLINE: Urochordata, Biological Products. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 282 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
In a growing multidrug-resistant environment, the identification of potential new drug candidates with an acceptable safety profile is a substantial crux in pharmaceutical discovery. This review discusses several aspects and properties of approved marine natural products derived from ascidian sources (phylum Chordata, subphylum Tunicata) and/or their deduced analogues including their biosynthetic origin, (bio)chemical preclinical assessments and known efficacy-safety profiles, clinical status in trials, but also translational developments, opportunities and final conclusions. The review also describes the preclinical assessments of a large number of other ascidian compounds that have not been involved in clinical trials yet. Finally, the emerging research on the connectivity of the ascidian hosts and their independent or obligate symbiotic guests is discussed. The review covers the latest information on the topic of ascidian-derived marine natural products over the last two decades including 2022, with the majority of publications published in the last decade.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aquatic Environment and Quality, Animal Sciences Unit, Flanders Research Institute for Agriculture, Fisheries and Food, Jacobsenstraat 1, BE-8400 Ostend, Belgium.
- Faculty of Pharmaceutical Sciences, Drug Quality and Registration Group, Ghent University, Ottergemsesteenweg 460, BE-9000 Ghent, Belgium.
- Technology and Food Science Unit, Flanders Research Institute for Agriculture, Fisheries and Food, Brusselsesteenweg 370, BE-9090 Melle, Belgium.
- Aquatic Environment and Quality, Animal Sciences Unit, Flanders Research Institute for Agriculture, Fisheries and Food, Jacobsenstraat 1, BE-8400 Ostend, Belgium. Electronic address: bavo.dewitte@ilvo.vlaanderen.be.
Zitieren
APA
Cooreman, K., De Spiegeleer, B., Van Poucke, C., Vanavermaete, D., Delbare, D., Wynendaele, E., & De Witte, B. (2023). Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives. Environmental Toxicology and Pharmacology. https://doi.org/10.1016/j.etap.2023.104254
Vancouver
Cooreman K, De Spiegeleer B, Van Poucke C, Vanavermaete D, Delbare D, Wynendaele E, et al. Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives. Environmental Toxicology and Pharmacology. 2023. doi:10.1016/j.etap.2023.104254
BibTeX
@article{Cooreman2023,
author = {Cooreman, Kris and De Spiegeleer, Bart and Van Poucke, Christof and Vanavermaete, David and Delbare, Daan and Wynendaele, Evelien and De Witte, Bavo},
title = {Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives},
journal = {Environmental Toxicology and Pharmacology},
year = {2023},
doi = {10.1016/j.etap.2023.104254}
}
EUVIMED